Development history and research progress of sentinel lymph node biopsy in breast cancer

Siyu WU; Junjie LI; Zhimin SHAO

doi:10.19401/j.cnki.1007-3639.2023.06.001

您当前的位置：

首页 >

文章列表页 >

Development history and research progress of sentinel lymph node biopsy in breast cancer

Specialists' Commentary | 更新时间：2025-12-31

- Development history and research progress of sentinel lymph node biopsy in breast cancer
- China Oncology Vol. 33, Issue 6, Pages: 551-559(2023)
- 作者机构：
  
  复旦大学附属肿瘤医院乳腺外科，复旦大学上海医学院肿瘤学系，上海200032
- 作者简介：
  
  SHAO Zhimin
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2023.06.001
  CLC： R737.9
- Received：10 May 2023，
  
  Revised：2023-06-01，
  
  Published：30 June 2023
- 稿件说明：
移动端阅览
Siyu WU, Junjie LI, Zhimin SHAO. Development history and research progress of sentinel lymph node biopsy in breast cancer[J]. China Oncology, 2023, 33(6): 551-559.
DOI：

Siyu WU, Junjie LI, Zhimin SHAO. Development history and research progress of sentinel lymph node biopsy in breast cancer[J]. China Oncology, 2023, 33(6): 551-559. DOI： 10.19401/j.cnki.1007-3639.2023.06.001.

摘要

乳腺癌前哨淋巴结活检术（sentinel lymph node biopsy，SLNB）是一项兼具诊断及治疗目的的外科技术，是近年来乳腺外科领域具有里程碑意义的重大进展之一。作为一种腋窝微创外科术式，在乳腺癌综合治疗效果不断提高的背景下，SLNB在近40年的发展呈现出降阶梯趋势，也从侧面反映出乳腺癌作为一种全身性疾病的生物学本质。首先，米兰SLNB185、NSABP-B32等一系列前瞻性随机对照临床试验证实，SLNB可以作为临床腋窝淋巴结阴性早期乳腺癌准确的腋窝分期手段。ACOSOG Z0011、IBCSG 23-01等临床试验结果则进一步丰富了腋窝外科手术降阶梯的概念，前哨淋巴结（sentinel lymph node，SLN）阳性的患者手术范围缩小，即SLN低肿瘤负荷患者中，SLNB可以安全替代腋窝淋巴结清扫（axillary lymph node dissection，ALND）。随后，SLNB以及由此衍生而来的标记淋巴结活检将腋窝微创手术的可行性人群范围进一步扩展到了新辅助治疗的患者。近年来，以EUBREAST-061为代表的回顾性研究及有限的前瞻性研究数据初步证实了腋窝降阶梯治疗在新辅助治疗患者中的肿瘤安全性。未来相关研究将聚焦在筛选寻找有望豁免SLNB的特定低危早期乳腺癌或者新辅助治疗后腋窝成功降期的超级反应者，有待于相关高质量临床研究如SOUND、BOOG 2013-08等临床试验长期随访数据的公布。本文就乳腺癌SLNB的发展历史、最新进展及未来展望进行综述，旨在为广大临床工作者提供参考。

Abstract

Sentinel lymph node biopsy (SLNB) is a surgical technique for diagnosing and treating purposes in breast cancer

which is one of the major advances with milestone significance in the field of breast surgery. As a less-invasive axillary surgery

the development of SLNB has shown a de-escalating trend in the recent 40 years

depending on the greatly improved efficacy of multidiscipline treatment in breast cancer

which indirectly reflects the essence that breast cancer is a systemic disease. First

a series of clinical trials such as Milan SLNB185 and NSABP-B32 confirmed that SLNB is an accurate axillary staging procedure for patients with clinically node-negative early breast cancer. Next

results from ACOSOG Z0011 and IBCSG 23-01 trials further enriched the concept of de-escalating axillary surgery in the sentinel lymph node (SLN)-positive patients and showed that routine axillary lymph node dissection (ALND) can be safely replaced by SLNB in patients with limited tumor burden present with SLN. Furthermore

SLNB and deriving clipped lymph node biopsy extend the target population of minimally invasive axillary surgery to the patients undergoing neoadjuvant therapy. In the recent few years

numerous retrospective studies represented by EUBREAST-061 study and a limited number of prospective studies have preliminarily confirmed the oncological safety of de-escalating axillary surgery in the setting of neoadjuvant therapy. In the future

related research will focus on finding suitable candidates for omitting SLNB including a selected group of low-risk early breast cancer or exceptional responders in neoadjuvant therapy

and the long-term follow-up data of relevant high-quality clinical trials such as SOUND and BOOG 2013-08 are yet to be mature. This article summarized the development history

research progress and future outlook of SLNB

in order to provide a reference for clinicians.

关键词

Keywords

references

马春雷 , 斋登 . 乳腺癌前哨淋巴结活检现状及研究进展 [J ] . 疾病监测与控制 , 2017 , 11 ( 5 ): 380 - 382 .

MA C L , ZHAI D . Current status and research progress of Sentinel lymph node biopsy in breast cancer [J ] . Dis Monitoring Control , 2017 , 11 ( 5 ): 380 - 382 .

周嵘 , 曾繁余 . 乳腺癌前哨淋巴结活检术的研究现状及展望 [J ] . 世界最新医学信息文摘 , 2019 , 19 ( 43 ): 68 - 70 .

ZHOU R , ZENG F Y . Research status and prospect of sentinel lymph node biopsy for breast cancer [J ] . World Latest Med Inform Digest , 2019 , 19 ( 43 ): 68 - 70 .

段学宁 . 乳腺癌手术治疗百年历史回顾与启示 [J ] . 中国实用外科杂志 , 2018 , 38 ( 11 ): 1227 - 1231 . DOI: 10.19538/j.cjps.issn1005-2208.2018.11.03 http://doi.org/10.19538/j.cjps.issn1005-2208.2018.11.03

DUAN X N . Centennial review and enlightenment of breast cancer surgery [J ] . China Ind Econ , 2018 , 38 ( 11 ): 1227 - 1231 .

王金礼 , 陈登峰 . 乳腺癌前哨淋巴结活检术的研究进展 [J ] . 河南医学研究 , 2017 , 26 ( 7 ): 1206 - 1208 .

WANG J L . CHEN D F . Research progress of sentinel lymph node biopsy in breast cancer [J ] . Henan Med Res , 2017 , 26 ( 7 ): 1206 - 1208 .

KRAG D N , ANDERSON S J , JULIAN T B , et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase Ⅲ trial [J ] . Lancet Oncol , 2007 , 8 ( 10 ): 881 - 888 . DOI: 10.1016/S1470-2045(07)70278-4 http://doi.org/10.1016/S1470-2045(07)70278-4 https://linkinghub.elsevier.com/retrieve/pii/S1470204507702784 https://linkinghub.elsevier.com/retrieve/pii/S1470204507702784

VERONESI U , PAGANELLI G , VIALE G , et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer [J ] . N Engl J Med , 2003 , 349 ( 6 ): 546 - 553 . DOI: 10.1056/NEJMoa012782 http://doi.org/10.1056/NEJMoa012782 http://www.nejm.org/doi/abs/10.1056/NEJMoa012782 http://www.nejm.org/doi/abs/10.1056/NEJMoa012782

MANSEL R E , FALLOWFIELD L , KISSIN M , et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial [J ] . J Natl Cancer Inst , 2006 , 98 ( 9 ): 599 - 609 . DOI: 10.1093/jnci/djj158 http://doi.org/10.1093/jnci/djj158

PROF , DAVID N , KRAG , et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial [J ] . Lancet Oncol , 2010 , 11 ( 10 ): 927 - 933 . DOI: 10.1016/S1470-2045(10)70207-2 http://doi.org/10.1016/S1470-2045(10)70207-2

HUNT K K , BALLMAN K V , MCCALL L M , et al. Factors associated with local-regional recurrence after a negative sentinel node dissection: results of the ACOSOG Z0010 trial [J ] . Ann Surg , 2012 , 256 ( 3 ): 428 - 436 .

LYMAN G H , GIULIANO A E , SOMERFIELD M R , et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer [J ] . J Clin Oncol , 2005 , 23 ( 30 ): 7703 - 7720 . DOI: 10.1200/JCO.2005.08.001 http://doi.org/10.1200/JCO.2005.08.001

GOLDHIRSCH A , WOOD W C , GELBER R D , et al. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007 [J ] . Ann Oncol , 2007 , 18 ( 7 ): 1133 - 1144 . DOI: 10.1093/annonc/mdm271 http://doi.org/10.1093/annonc/mdm271

王永胜 , 欧阳涛 , 王启堂 , 等 . 中国前哨淋巴结活检多中心协作研究CBCSG-001最新资料报告 [J ] . 中华乳腺病杂志(电子版) , 2009 , 3 ( 3 ): 8 - 12 .

WANG Y S , OUYANG T , WANG Q T , et al. Chinese joint multi-center study of sentinel lymph node biopsy (CBCSG-001): latest news [J ] . Chin J Breast Dis Electron Version , 2009 , 3 ( 3 ): 8 - 12 .

中国抗癌协会乳腺癌专业委员会 . 中国抗癌协会乳腺癌诊治指南与规范(2021年版) [J ] . 中国癌症杂志 , 2021 , 31 ( 10 ): 954 - 1040 .

The Society of Breast Cancer China Anti-Cancer Association . Guidelines for breast cancer diagnosis and treatment by China Anti-Cancer Association (2021 edition) [J ] . China Oncol , 2021 , 31 ( 10 ): 954 - 1040 .

VAN ZEE K J , MANASSEH D M E , BEVILACQUA J L B , et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy [J ] . Ann Surg Oncol , 2003 , 10 ( 10 ): 1140 - 1151 . DOI: 10.1245/aso.2003.03.015 http://doi.org/10.1245/aso.2003.03.015

KOHRT H E , OLSHEN R A , BERMAS H R , et al. New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients [J ] . BMC Cancer , 2008 , 8 : 66 . DOI: 10.1186/1471-2407-8-66 http://doi.org/10.1186/1471-2407-8-66

GIULIANO A E , BALLMAN K V , MCCALL L , et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (alliance) randomized clinical trial [J ] . JAMA , 2017 , 318 ( 10 ): 918 - 926 . DOI: 10.1001/jama.2017.11470 http://doi.org/10.1001/jama.2017.11470 http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2017.11470 http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2017.11470

BARTELS S A L , DONKER M , PONCET C , et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-year results of the randomized controlled EORTC 10981-22023 AMAROS trial [J ] . J Clin Oncol , 2023 , 41 ( 12 ): 2159 - 2165 . DOI: 10.1200/JCO.22.01565 http://doi.org/10.1200/JCO.22.01565 https://ascopubs.org/doi/10.1200/JCO.22.01565 https://ascopubs.org/doi/10.1200/JCO.22.01565

GALIMBERTI V , COLE B F , VIALE G , et al. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial [J ] . Lancet Oncol , 2018 , 19 ( 10 ): 1385 - 1393 . DOI: S1470-2045(18)30380-2 http://doi.org/S1470-2045(18)30380-2

PROF , THORSTEN , KUEHN , et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study [J ] . Lancet Oncol , 2013 , 14 ( 7 ): 609 - 618 . DOI: 10.1016/S1470-2045(13)70166-9 http://doi.org/10.1016/S1470-2045(13)70166-9

BOUGHEY J C , SUMAN V J , MITTENDORF E A , et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial [J ] . JAMA , 2013 , 310 ( 14 ): 1455 - 1461 . DOI: 10.1001/jama.2013.278932 http://doi.org/10.1001/jama.2013.278932

BOILEAU J F , POIRIER B , BASIK M , et al. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study [J ] . J Clin Oncol , 2015 , 33 ( 3 ): 258 - 264 .

BOUGHEY J C , SUMAN V J , MITTENDORF E A , et al. Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance) [J ] . Ann Surg , 2015 , 261 ( 3 ): 547 - 552 . DOI: 10.1097/SLA.0000000000000551 http://doi.org/10.1097/SLA.0000000000000551

BOUGHEY J C , BALLMAN K V , LE-PETROSS H T , et al. Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node su rgery in patients presenting with node-positive breast cancer (T 0 -T 4 , N 1 -N 2 ) who receive neoadjuvant chemotherapy: results from ACOSOG Z1071 (alliance) [J ] . Ann Surg , 2016, 263(4): 802-807.

DONKER M , STRAVER M E , WESSELING J , et al. Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure [J ] . Ann Surg , 2015 , 261 ( 2 ): 378 - 382 . DOI: 10.1097/SLA.0000000000000558 http://doi.org/10.1097/SLA.0000000000000558

CAUDLE A S , YANG W T , MITTENDORF E A , et al. Selective surgical localization of axillary lymph nodes containing metastases in patients with breast cancer: a prospective feasibility trial [J ] . JAMA Surg , 2015 , 150 ( 2 ): 137 - 143 . DOI: 10.1001/jamasurg.2014.1086 http://doi.org/10.1001/jamasurg.2014.1086

CAUDLE A S , YANG W T , KRISHNAMURTHY S , et al. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection [J ] . J Clin Oncol , 2016 , 34 ( 10 ): 1072 - 1078 . DOI: 10.1200/JCO.2015.64.0094 http://doi.org/10.1200/JCO.2015.64.0094

SIMONS J M , VAN NIJNATTEN T J A , VAN DER POL C C , et al. Diagnostic accuracy of radioactive iodine seed placement in the axilla with sentinel lymph node biopsy after neoadjuvant chemotherapy in node-positive breast cancer [J ] . JAMA Surg , 2022 , 157 ( 11 ): 991 - 999 . DOI: 10.1001/jamasurg.2022.3907 http://doi.org/10.1001/jamasurg.2022.3907 https://jamanetwork.com/journals/jamasurgery/fullarticle/2795851 https://jamanetwork.com/journals/jamasurgery/fullarticle/2795851

BRACKSTONE M , BALDASSARRE F G , PERERA F E , et al. Management of the axilla in early-stage breast cancer: Ontario health (cancer care Ontario) and ASCO guideline [J ] . J Clin Oncol , 2021 , 39 ( 27 ): 3056 - 3082 . DOI: 10.1200/JCO.21.00934 http://doi.org/10.1200/JCO.21.00934 https://ascopubs.org/doi/10.1200/JCO.21.00934 https://ascopubs.org/doi/10.1200/JCO.21.00934

VUGTS G , MAASKANT-BRAAT A J , DE ROOS W K , et al. Management of the axilla after neoadjuvant chemotherapy for clinically node positive breast cancer: a nationwide survey study in the Netherlands [J ] . Eur J Surg Oncol , 2016 , 42 ( 7 ): 956 - 964 . DOI: 10.1016/j.ejso.2016.03.023 http://doi.org/10.1016/j.ejso.2016.03.023

CAUDLE A S , BEDROSIAN I , MILTON D R , et al. Use of sentinel lymph node dissection after neoadjuvant chemotherapy in patients with node-positive breast cancer at diagnosis: practice patterns of American Society of Breast Surgeons Members [J ] . Ann Surg Oncol , 2017 , 24 ( 10 ): 2925 - 2934 . DOI: 10.1245/s10434-017-5958-4 http://doi.org/10.1245/s10434-017-5958-4

WU S Y , WANG Y J , ZHANG N , et al. Intraoperative touch imprint cytology in targeted axillary dissection after neoadjuvant chemotherapy for breast cancer patients with initial axillary metastasis [J ] . Ann Surg Oncol , 2018 , 25 ( 11 ): 3150 - 3157 . DOI: 10.1245/s10434-018-6548-9 http://doi.org/10.1245/s10434-018-6548-9

WU S , WANG Y , LI J , et al. Subtype-guided 18 F-FDG PET/CT in tailoring axillary surgery among patients with node-positive breast cancer treated with neoadjuvant chemotherapy: a feasibility study [J ] . Oncologist , 2020 , 25 ( 4 ): e626 -e633. DOI: 10.1634/theoncologist.2019-0583 http://doi.org/10.1634/theoncologist.2019-0583 https://academic.oup.com/oncolo/article/25/4/e626/6443252 https://academic.oup.com/oncolo/article/25/4/e626/6443252

WU S Y , LI J W , WU H L , et al. Accuracy of ultrasound-guided targeted fine-needle aspiration in assessing nodal response in node-positive breast cancer after neoadjuvant chemotherapy: prospective feasibility study [J ] . Br J Surg , 2022 , 109 ( 12 ): 1194 - 1197 . DOI: 10.1093/bjs/znac277 http://doi.org/10.1093/bjs/znac277 https://academic.oup.com/bjs/article/109/12/1194/6677263 https://academic.oup.com/bjs/article/109/12/1194/6677263

WU S Y , LI J W , ZHANG Y , et al. Repeated core needle biopsy and targeted fine-needle aspiration to optimize axillary surgery after neoadjuvant chemotherapy in node-positive breast cancer: a prospective clinical study [J ] . Br J Surg , 2023 : znad106 .

PILTIN M A , HOSKIN T L , DAY C N , et al. Oncologic outcomes of sentinel lymph node surgery after neoadjuvant chemotherapy for node-positive breast cancer [J ] . Ann Surg Oncol , 2020 , 27 ( 12 ): 4795 - 4801 . DOI: 10.1245/s10434-020-08900-0 http://doi.org/10.1245/s10434-020-08900-0

BARRIO A V , MONTAGNA G , MAMTANI A , et al. Nodal recurrence in patients with node-positive breast cancer treated with sentinel node biopsy alone after neoadjuvant chemotherapy-a rare event [J ] . JAMA Oncol , 2021 , 7 ( 12 ): 1851 - 1855 . DOI: 10.1001/jamaoncol.2021.4394 http://doi.org/10.1001/jamaoncol.2021.4394

MARTELLI G , BARRETTA F , MICELI R , et al. Sentinel node biopsy alone or with axillary dissection in breast cancer patients after primary chemotherapy: long-term results of a prospective interventional study [J ] . Ann Surg , 2022 , 276 ( 5 ): e544 -e552. DOI: 10.1097/SLA.0000000000004562 http://doi.org/10.1097/SLA.0000000000004562 https://journals.lww.com/10.1097/SLA.0000000000004562 https://journals.lww.com/10.1097/SLA.0000000000004562

WU S Y , LI J W , WANG Y J , et al. Clinical feasibility and oncological safety of non-radioactive targeted axillary dissection after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: a prospective diagnostic and prognostic study [J ] . Int J Surg , 2023 . Online ahead of print .

BURSTEIN H J , CURIGLIANO G , LOIBL S , et al. Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019 [J ] . Ann Oncol , 2019 , 30 ( 10 ): 1541 - 1557 . DOI: S0923-7534(19)60978-6 http://doi.org/S0923-7534(19)60978-6

JATOI I , KUNKLER I H . Omission of sentinel node biopsy for breast cancer: historical context and future perspectives on a modern controversy [J ] . Cancer , 2021 , 127 ( 23 ): 4376 - 4383 . DOI: 10.1002/cncr.33960 http://doi.org/10.1002/cncr.33960

TADROS A B , YANG W T , KRISHNAMURTHY S , et al. Identification of patients with documented pathologic complete response in the breast after neoadjuvant chemotherapy for omission of axillary surgery [J ] . JAMA Surg , 2017 , 152 ( 7 ): 665 - 670 . DOI: 10.1001/jamasurg.2017.0562 http://doi.org/10.1001/jamasurg.2017.0562

BARRON A U , HOSKIN T L , DAY C N , et al. Association of low nodal positivity rate among patients with ERBB2-positive or triple-negative breast cancer and breast pathologic complete response to neoadjuvant chemotherapy [J ] . JAMA Surg , 2018 , 153 ( 12 ): 1120 . DOI: 10.1001/jamasurg.2018.2696 http://doi.org/10.1001/jamasurg.2018.2696

FAYANJU O M , REN Y , THOMAS S M , et al. The clinical significance of breast-only and node-only pathologic complete response (pCR) after neoadjuvant chemotherapy (NACT): a review of 20 000 breast cancer patients in the national cancer data base (NCDB) [J ] . Ann Surg , 2018 , 268 ( 4 ): 591 - 601 . DOI: 10.1097/SLA.0000000000002953 http://doi.org/10.1097/SLA.0000000000002953 https://journals.lww.com/00000658-201810000-00006 https://journals.lww.com/00000658-201810000-00006

PFOB A , SIDEY-GIBBONS C , RAUCH G , et al. Intelligent vacuum-assisted biopsy to identify breast cancer patients with pathologic complete response (ypT 0 and ypN 0 ) after neoadjuvant systemic treatment for omission of breast and axillary surgery [J ] . J Clin Oncol , 2022 , 40 ( 17 ): 1903 - 1915 . DOI: 10.1200/JCO.21.02439 http://doi.org/10.1200/JCO.21.02439 https://ascopubs.org/doi/10.1200/JCO.21.02439 https://ascopubs.org/doi/10.1200/JCO.21.02439

Views

4652

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Research on the association of breast cancer patients’ prognosis with internal mammary sentinel lymph node biopsy

Retrospective study on regional lymph node radiotherapy after axillary dissection exemption in breast cancer patients with sentinel lymph node positive status

Progress and future prospects in local and systemic treatment of early breast cancer

Feasibility analysis of sentinel lymph node biopsy in breast cancer with axilla negative evaluation by physical examination but suspicious lymph nodes finding on preoperative imaging and metastasis confirmed with biopsy

New concept of de-escalation management strategy in breast cancer patients with 1-2 positive sentinel lymph nodes

Related Author

Ruijie JIA

Zhiqiang SHI

Qi ZHANG

Yongjin LU

Junsheng ZHENG

Jing SUN

Zhao BI

Xiao SUN

Related Institution

Shandong First Medical University Affiliated Tumor Hospital (Shandong Provincial Institute of Cancer Prevention and Treatment, Shandong Cancer Hospital)

Shandong First Medical University (Shandong Provincial Academy of Medical Sciences)

Tianjin Medical University Cancer Institute and Hospital

Shandong First Medical University Affiliated Cancer Hospital (Shandong Cancer Prevention and Treatment Research Institute, Shandong Cancer Hospital)

Shandong First Medical University (Shandong Academy of Medical Sciences)

AI问答

⁰